Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.1 USD | +1.76% | -9.48% | -10.12% |
05-09 | Earnings Flash (INMB) INMUNE BIO Reports Q1 Revenue $14,000 | MT |
05-09 | Transcript : INmune Bio, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.12% | 196M | |
+4.66% | 111B | |
+11.34% | 105B | |
-12.01% | 22.34B | |
-3.81% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-9.43% | 16.96B | |
+3.20% | 13.7B | |
+37.01% | 12.45B |
- Stock Market
- Equities
- INMB Stock
- News INmune Bio, Inc.
- B. Riley Downgrades INmune Bio to Neutral from Buy on Chemistry Manufacturing and Controls-Related FDA Hold, Lowers Price Target to $7 from $14